Advertisement

Topics

Orion Pharma AB Company Profile

18:49 EST 14th December 2018 | BioPortfolio

Nil

Location

Djupdalsvägen 7
Sollentuna
192 51

Contact

Phone: 08-623 64 40
Fax: 08-623 64 80
Email: info@orionpharma.se


News Articles [578 Associated News Articles listed on BioPortfolio]

Orion Corporation: Licenses and Growth for Mid-size Companies in Europe

In this episode of PharmaTelevision News Review, Fintan Walton talks with Jukka Muhonen at Orion Corporation. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss: • Orion's origins a...

M&As this week: Orion Biotechnology Canada, SOPHiA GENETICS, GI Partners

Orion Biotechnology Canada has completed the acquisition of K2Biomedical for an undisclosed sum. K2Biomedical will operate as Orion Biotechnology Poland,...Read More... The post M&As this week: O...

Orion divests Orion Diagnostica division to PE firm Axcel for up to €223mm

An investment fund managed by Nordic private equity investment company Axcel Management AS agreed to acquire Orion Diagnostica Oy (point-of-care testing instruments and kits) for a fixed price of €1...

Bayer, Orion drug shown to delay spread of prostate cancer

German drugmaker Bayer and Finland's Orion said on Wednesday a study showed a prostate cancer drug they are jointly developing can delay the spread of the disease to other parts of the body, boosting ...

MTBC Successfully Closes Orion, Largest Acquisition to Date

Company Acquires Assets of Orion Healthcorp, Inc. and its 13 Affiliates SOMERSET, N.J.,, July 02, 2018 (GLOBE NEWSWIRE) Read more...

Orion Health Selling its Rhapsody Platform for $205 Million

David RathsNew Zealand-based Orion Health Group announced that it will sell its Rhapsody business unit for $205 million to private equity firm Hg. The U.K.-based firm will also take a quarter stake in...

Orion enrols first patient in REFALS trial of levosimendan

Orion has enrolled the first patient in the REFALS trial, a Phase III clinical study of levosimendan (ODM-109) for the...Read More... The post Orion enrols first patient in REFALS trial of levosimenda...

Amgen collaborates with Orion to market Amgevita in Finland

The Orion Group announced on 24 October 2018 that it will distribute Amgen’s adalimumab biosimilar in Finland.

Drugs and Medications [239 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [22 Associated PubMed Articles listed on BioPortfolio]

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

The Safety and Accuracy of the RHYTHMIA Mapping System in Pediatric Patients.

A new mapping system (Rhythmia) using a 64 mini-electrode small basket array (Orion) was developed and enables rapid high-density mapping in a short time. However, there are few reports about the usef...

Disease awareness advertising (DAA) in emerging economy: A comparison between views of consumers and pharmaceutical professionals.

Research on effectiveness of DAA is limited. Existing researches explore impact of DAA only on relationship between drug manufacturers and consumers. However, in reality, pharma marketing revolves aro...

21 Century Citizen Pharma: The FDA & Patient-Focused Product Development.

Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...

Clinical Trials [97 Associated Clinical Trials listed on BioPortfolio]

Early Feasibility Study of the Orion Visual Cortical Prosthesis System

This is an early feasibility study of a new device, the Orion Visual Cortical Prosthesis System. The device is intended to stimulate the surface of the visual cortex to induce visual perce...

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Companies [803 Associated Companies listed on BioPortfolio]

Orion Pharma AB

Nil

Orion Research LLC

Orion Research LLC provides investigative research on public companies and was hired by Pershing Square Capital Management, L.P. to gather information on Herbalife and its Nutriti...

Orion Energy Systems, Inc.

Orion is leading the transformation of commercial and industrial buildings with state-of-the-art energy efficient lighting systems and retrofit lighting solutions. Orion manufactu...

Orion Health, Inc.

Orion Health™ is the leading Health Information Exchange (HIE) solution provider with expertise in clinical workflow and integration technology for the healthcare sector. Ori...

Orion Therapeutics, LLC

Orion Therapeutics is a Troy, Michigan-based biotech company with a mission to discover, develop and commercialize novel products derived from neutraceutical and food supplement m...

More Information about "Orion Pharma AB" on BioPortfolio

We have published hundreds of Orion Pharma AB news stories on BioPortfolio along with dozens of Orion Pharma AB Clinical Trials and PubMed Articles about Orion Pharma AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Orion Pharma AB Companies in our database. You can also find out about relevant Orion Pharma AB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record